Zoliflodacin Bioequivalence and Drug-Drug Interaction Study
Status:
Recruiting
Trial end date:
2023-02-23
Target enrollment:
Participant gender:
Summary
this study will be a Phase 1, single-dose, two parallel cohorts, open-label, randomized study
in healthy subjects with Cohort 1 as bioequivalence (BE) and food effect study and Cohort 2
as a drug-drug interaction (DDI) study.
Phase:
Phase 1
Details
Lead Sponsor:
Global Antibiotics Research and Development Partnership